Hi, what are you looking for?

New Delhi – 17th June, 2022 – Genes2Me Pvt. Ltd., one of the leading IVD solution manufacturer of India, is elated to announce the launch of its CoviEasy Self-Test Rapid Antigen test kit for COVID-19 that is easy to use and give faster results in 10 minutes. Backed by AI driven Mobile App, this IVD product delivers high level of sensitivity and concordance of more than 98% accuracy. 

CoviEasy has undergone stringent quality checks at ICMR approved Validation center and further received approval from CDSCO India. The Central Drugs Standard Control Organization (CDSCO) under Directorate General of Health Services, Ministry of Health & Family Welfare, and Government of India is the National Regulatory Authority (NRA) of India. CDSCO is constantly thriving upon to bring out transparency, accountability and uniformity in its services in order to ensure safety, efficacy and quality of the medical product manufactured, imported and distributed in the country. CoviEasy test can be easily performed by following simple instructions provided on the Mobile App (which is available on both Android and iOS platforms) leading to Automated Reporting of test results from this Mobile App itself.

Rapid antigen tests are now more accessible in supermarkets and pharmacies, so it is important that we know how to use them correctly. The CoviEasy test involves couple of easy and simple steps as is conducted with a nasal swab sampling, wherein the swab first need to be inserted in the nostrils. The swab needs to be dipped in the buffer tube and swirl 8-10 times in the extraction buffer. The Buffer is then dropped onto the CoviEasy test device which shows test result as either positive or negative. The test device also comes with a unique QR code for unique patient data entry and accurate report generation. 

Mr. Neeraj Gupta, the Founder and CEO of Genes2Me Pvt. Ltd. while commenting on the launch of product said, “Now that many of us are opting for “At home” test kits as our first line of defense against Covid, “Accuracy” becomes non-negotiable/most Important factor. We understood the need of the hour and came up with a test kit which is more than 98% accurate. Our CoviEasy kit will provide almost the assurances of RTPCR with the convenience of “at home” self-test kit. We plan to help the society with India’s most accurate kit and meet the requirement with our advanced manufacturing unit.”

As per ICMR and Ministry of Health & Family Welfare (MoH&FW) protocol, all individuals who test positive onto Self-Testing Kits may be considered as true positives and no repeat testing is required. 

Genes2Me Pvt. Ltd., founded in 2016, is now one of India’s leading companies in the field of IVD Kit manufacturing and molecular diagnostics. Genes2Me has State-of-Art manufacturing facility for IVD kits and has worked tirelessly to provide people with high-quality IVD Kits and Point of care solutions for last so many years. It has provided lot of premium quality IVD solutions for COVID-19 such as Real-Time PCR Kits, RNA Extraction Kits, Rapid Tests.

Next-Generation Sequencing (NGS) Kits and Multiplexed Genotyping assays. These IVD kits have demonstrated accuracy, sensitivity, and specificity, as well as the ability to deliver faster results.

All Genes2Me products listed above are by Genes2Me Private Limited. For more information, visit www.genes2me.com.

Media Contact Company Name: Genes2Me – CoviEasy Contact Person: Mukesh Kumar Email: Send Email Phone: 1001214030 Address:1105, SAS Tower Medicity, Sector-38 City: Gurugram State: Haryana Country: India Website: https://www.covieasy.com/

Clear thinking isn’t exactly at plague levels, either.

Dozens of artists are busy this June painting giant frescoes for the tenth edition of Montreal's Mural festival.

Gazelles at an Iraqi wildlife reserve are dropping dead from hunger, making them the latest victims of climate change, compounding hardships.

Smoke and dirt rise from the city of Severodonetsk in the eastern Ukrainian region of Donbas on Friday, as the Russian-Ukrainian war enters its...

COPYRIGHT © 1998 - 2022 DIGITAL JOURNAL INC. Digital Journal is not responsible for the content of external sites. Read more about our external linking.